An Aged Canid with Behavioral Deficits Exhibits Blood and Cerebrospinal Fluid Amyloid Beta Oligomers

被引:11
|
作者
Rusbridge, Clare [1 ,2 ]
Salguero, Francisco J. [1 ]
David, Monique Antoinette [3 ]
Faller, Kiterie M. E. [4 ]
Bras, Jose T. [5 ,6 ,7 ]
Guerreiro, Rita J. [5 ,6 ,7 ]
Richard-Londt, Angela C. [8 ,9 ]
Grainger, Duncan [1 ]
Head, Elizabeth [10 ]
Brandner, Sebastian G. P. [8 ,9 ]
Summers, Brian
Hardy, John
Tayebi, Mourad [1 ,3 ]
机构
[1] Univ Surrey, Fac Hlth & Med Sci, Dept Pathol & Infect Dis, Guildford, Surrey, England
[2] Fitzpatrick Referrals, Godalming, Surrey, England
[3] Western Sydney Univ, Sch Med, Campbelltown, NSW, Australia
[4] Univ Glasgow, Sch Vet Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland
[5] UCL, Inst Neurol, Dept Mol Neurosci, London, England
[6] Univ Aveiro, Dept Med Sci, Aveiro, Portugal
[7] Univ Aveiro, Inst Biomed iBiMED, Aveiro, Portugal
[8] UCL, Inst Neurol, Div Neuropathol, London, England
[9] UCL, Inst Neurol, Dept Neurodegenerat Dis, London, England
[10] Univ Kentucky, Sanders Brown Ctr Aging, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA
来源
关键词
canine cognitive dysfunction; Alzheimer; canine; A beta oligomers; neuropathology; aggregation; neurotoxicity; ALZHEIMERS-DISEASE; BRAIN; DOGS; ANTIBODIES; PROTEINS; PATHWAY; MODEL;
D O I
10.3389/fnagi.2018.00007
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Many of the molecular and pathological features associated with human Alzheimer disease (AD) are mirrored in the naturally occurring age-associated neuropathology in the canine species. In aged dogs with declining learned behavior and memory the severity of cognitive dysfunction parallels the progressive build up and location of A beta in the brain. The main aim of this work was to study the biological behavior of soluble oligomers isolated from an aged dog with cognitive dysfunction through investigating their interaction with a human cell line and synthetic A beta peptides. We report that soluble oligomers were specifically detected in the dog's blood and cerebrospinal fluid (CSF) via anti-oligomer-and anti-A beta specific binders. Importantly, our results reveal the potent neurotoxic effects of the dog's CSF on cell viability and the seeding efficiency of the CSF-borne soluble oligomers on the thermodynamic activity and the aggregation kinetics of synthetic human A beta. The value of further characterizing the naturally occurring Alzheimer-like neuropathology in dogs using genetic and molecular tools is discussed.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Amyloid-β Peptide and Oligomers in the Brain and Cerebrospinal Fluid of Aged Canines
    Head, Elizabeth
    Pop, Viorela
    Sarsoza, Floyd
    Kayed, Rakez
    Beckett, Tina L.
    Studzinski, Christa M.
    Tomic, Jennifer L.
    Glabe, Charles G.
    Murphy, M. Paul
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (02) : 637 - 646
  • [2] Amyloid-beta plasma and cerebrospinal fluid biomarkers in aged dogs with cognitive dysfunction syndrome
    Stylianaki, Ioanna
    Polizopoulou, Zoe S.
    Theodoridis, Alexandros
    Koutouzidou, Georgia
    Baka, Rania
    Papaioannou, Nikolaos G.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2020, 34 (04) : 1532 - 1540
  • [3] Diffuse beta-amyloid plaques and hyperphosphorylated tau are unrelated processes in aged dogs with behavioral deficits
    Marco Pugliese
    Joan Mascort
    Nicole Mahy
    Isidro Ferrer
    Acta Neuropathologica, 2006, 112 : 175 - 183
  • [4] Methods for the Specific Detection and Quantitation of Amyloid-β Oligomers in Cerebrospinal Fluid
    Schuster, Judith
    Funke, Susanne Aileen
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 53 (01) : 53 - 67
  • [5] Diffuse beta-amyloid plaques and hyperphosphorylated tau are unrelated processes in aged dogs with behavioral deficits
    Pugliese, Marco
    Mascort, Joan
    Mahy, Nicole
    Ferrer, Isidro
    ACTA NEUROPATHOLOGICA, 2006, 112 (02) : 175 - 183
  • [6] Quantification of amyloid-beta 40 in cerebrospinal fluid
    Verwey, Nicolaas A.
    Veerhuis, Robert
    Twaalfhoven, Harry A. M.
    Wouters, Dorine
    Hoozemans, Jeroen J. M.
    Bollen, Yves J. M.
    Killestein, Joep
    Bibl, Mirko
    Wiltfang, Jens
    Hack, C. Erik
    Scheltens, Philip
    Blankenstein, Marinus A.
    JOURNAL OF IMMUNOLOGICAL METHODS, 2009, 348 (1-2) : 57 - 66
  • [7] A Luminex Assay Detects Amyloid β Oligomers in Alzheimer's Disease Cerebrospinal Fluid
    Herskovits, Adrianna Z.
    Locascio, Joseph J.
    Peskind, Elaine R.
    Li, Ge
    Hyman, Bradley T.
    PLOS ONE, 2013, 8 (07):
  • [8] Target engagement in an alzheimer trial: Crenezumab lowers amyloid β oligomers in cerebrospinal fluid
    Yang, Ting
    Dang, Yifan
    Ostaszewski, Beth
    Mengel, David
    Steffen, Verena
    Rabe, Christina
    Bittner, Tobias
    Walsh, Dominic M.
    Selkoe, Dennis J.
    ANNALS OF NEUROLOGY, 2019, 86 (02) : 215 - 224
  • [9] Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer's Disease
    Holtta, Mikko
    Hansson, Oskar
    Andreasson, Ulf
    Hertze, Joakim
    Minthon, Lennart
    Nagga, Katarina
    Andreasen, Niels
    Zetterberg, Henrik
    Blennow, Kaj
    PLOS ONE, 2013, 8 (06):
  • [10] Reduced cerebrospinal fluid levels of α-secretase-cleaved amyloid precursor protein in aged rats:: Correlation with spatial memory deficits
    Anderson, JJ
    Holtz, G
    Baskin, PP
    Wang, R
    Mazzarelli, L
    Wagner, SL
    Menzaghi, F
    NEUROSCIENCE, 1999, 93 (04) : 1409 - 1420